Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors

• Published in: Scientific reports Vol. 11; no. 1; p. 5680
• Main Authors: Izumi, Motohiro, Oyanagi, Jun, Sawa, Kenji, Fukui, Mitsuru, Ogawa, Koichi, Matsumoto, Yoshiya, Tani, Yoko, Suzumura, Tomohiro, Watanabe, Tetsuya, Kaneda, Hiroyasu, Mitsuoka, Shigeki, Asai, Kazuhisa, Ohsawa, Masahiko, Yamamoto, Nobuyuki, Koh, Yasuhiro, Kawaguchi, Tomoya
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 11.03.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 631/67/1612/1350; 631/67/395; Aged; Aged, 80 and over; Epidermal growth factor receptors; Female; Genetic analysis; Humanities and Social Sciences; Humans; Lung cancer; Lung Neoplasms - genetics; Lung Neoplasms - pathology; Lung Neoplasms - surgery; Male; Middle Aged; multidisciplinary; Mutation; Mutation - genetics; p53 Protein; Poly(ADP-ribose) polymerase; Risk Factors; Science; Science (multidisciplinary); Sequence Analysis, DNA; Tumors
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-83609-y

Multiple primary lung cancers (MPLCs) harbour various genetic profiles among the tumours, even from individuals with same non-intrinsic risk factors. Paired mutational analyses were performed to obtain a census of mutational events in MPLC and assess their relationship with non-intrinsic risk factors. Thirty-eight surgical specimens from 17 patients diagnosed as MPLC were used. Extracted DNAs were sequenced for somatic mutations in 409 cancer-associated genes from a comprehensive cancer panel. We statistically analysed the correlation between each driver mutation frequency and non-intrinsic risk factors using Fisher's exact test, and whether genetic mutations occurred concomitantly or randomly in MPLC using an exact test. Comprehensive genetic analyses suggested different mutation profiles in tumours within the same individuals, with some exceptions. EGFR , KRAS, TP53 , or PARP1 mutations were concomitantly detected in some MPLC cases. EGFR mutations were significantly more frequent in never or light smokers and females. Concomitant EGFR or KRAS mutations in MPLCs were significantly more frequent than expected by chance ( P  = .0023 and .0049, respectively) suggesting a more prominent role of non-intrinsic risk factors in EGFR and KRAS mutations than other mutations, which occurred more randomly. Concomitant EGFR or KRAS mutations were particularly prominent in never or light smokers and males.